SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001493152-21-006548
Filing Date
2021-03-22
Accepted
2021-03-22 17:21:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 form425.htm 425 22345
  Complete submission text file 0001493152-21-006548.txt   24175
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 856-848-8698
Akers Biosciences, Inc. (Filed by) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 856-848-8698
Akers Biosciences, Inc. (Subject) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36268 | Film No.: 21762169
SIC: 2835 In Vitro & In Vivo Diagnostic Substances